Previous studies have demonstrated that activation of Kit by stem cell factor (SCF), its natural ligand, or by gainof-function point mutation in its intracellular domain, confers signi®cant protection against apoptosis induced by growth factor deprivation or radiation. However, the eects of Kit activation on the cellular response to antitumor agents have not been so extensively documented. This study shows that daunorubicin-induced apoptosis and cytotoxicity were reduced in the murine Ba/F3 cells transfected with Kit (Ba/F3-Kit) in the presence of SCF and in Ba/F3 cells transfected with a constitutively active Kit variant (Ba/F3-KitD27), compared to either parental Ba/F3 (Ba/F3-wt) or unstimulated Ba/F3-Kit cells. In Ba/F3-wt and in Ba/F3-Kit cells, daunorubicin stimulated within 8 ± 15 min neutral sphingomyelinase and ceramide production but not in SCF-stimulated Ba/F3-Kit or in Ba/F3-KitD27 whereas all Ba/F3 cells were equally sensitive to exogenous cell-permeant C6-ceramide. In Ba/F3-Kit, SCF-induced Kit activation resulted in a rapid phospholipase Cg (PLCg) tyrosine phosphorylation followed by diacylglycerol release and protein kinase C (PKC) stimulation. U-73122, a PLCg inhibitor, not only blocked diacylglycerol production and PKC stimulation but also restored daunorubicin-induced sphingomyelinase stimulation, ceramide production, and apoptosis. These results suggest that Kit activation results in PLCg-mediated PKC-dependent sphingomyelinase inhibition which contributes to drug resistance in Kit-related malignancies. Oncogene (2001) 20, 6752 ± 6763.
Introduction
Daunorubicin (DNR) is among the most active antileukemic agents. DNR cytotoxicity is generally thought to be the result of drug-induced damage to DNA. This damage is mediated by quinone-generated redox activity, intercalation-distorsion of the double helix, or stabilization of the cleavable complex formed between DNA and topoisomerase II (Chabner and Myers, 1989) . Recently, we demonstrated that DNR can trigger apoptosis in certain leukemic cellular models (Quillet-Mary et al., 1996) . In further studies, we showed that, at least in some leukemic cellular models, DNR activates the sphingomyelin (SM)-ceramide (CER) cycle leading to apoptosis. Indeed, DNR stimulated neutral sphingomyelinase (N-SMase) activity responsible for SM hydrolysis and subsequent CER generation in leukemic cells (Allouche et al., 1997 (Allouche et al., , 2000 BettaõÈ eb et al., 1999; CoÃ me et al., 1999; JareÂ zou et al., 1996; Mansat et al., 1997a,b) . The fact that cell-permeant CER as well as natural CER (generated by exposure of the cells to bacterial SMase) induce apoptosis in these cells strongly suggests that CER plays an important role in DNR-induced apoptosis. Such an apoptotic pathway has also been described in vincristine, ionizing radiation, Fas agonist, and Tumor Necrosis Factor a (Hannun, 1996) . However, other signaling pathways may greatly in¯uence SM-CER pathway. For example, it has been recently described that phosphoinositide-3 kinase (PI3K) stimulation decreases CER accumulation (Burow et al., 2000) . In previous studies, we have reported that phorbol ester-or diacylglycerol (DAG)-induced protein kinase C (PKC) activation limits DNR-induced SMase stimulation, CER generation, and apoptosis Mansat et al., 1997b) whereas it has been described that DAG inhibits CER-induced apoptosis (Jarvis et al., 1994) . These results suggest that external or internal stimuli, which result in PI3K stimulation or in DAG production and subsequent PKC stimulation, may seriously interfere with DNR-activated SM cycle and apoptosis, and therefore could in¯uence DNR-induced cytotoxicity.
The proto-oncogene, c-kit, encodes a class III receptor tyrosine kinase (RTK) that is a member of the same membrane-bound RTK subfamily as the receptors for platelet-derived growth factor, colony stimulating factor-1, and Flt3. This RTK subfamily is characterized by an extracellular ligand binding domain and an intracellular kinase domain. The ligand for the c-kit product (Kit) has been genetically mapped to the steel locus (Sl), and is variously referred to as SCF, mast cell growth factor, kit ligand, or steel factor. Activation of Kit by binding to SCF promotes Kit dimerization, auto-and transphosphorylation of Kit at speci®c tyrosine residues that can serve as docking sites for src-homology-2 (SH2) domain-containing signaling molecules, including PI3K and phospholipase C (PLC)g (Caruana et al., 1999; Feng et al., 1998; Herbst et al., 1995; Rottapel et al., 1991; Sette et al., 1998) . PLCg induces phosphatidylinositol (PI) 4,5-bisphosphate hydrolysis and production of DAG and inositol 1,4,5-trisphosphate. These two messengers induce PKC activation and intracellular Ca 2+ release, respectively (Rhee and Bae, 1997) . Therefore, it is reasonable to speculate that Kit activation may alter the apoptotic response to DNR by interfering with the SM-CER pathway through a PI-PLC-and/or PKC-dependent mechanism. Alternatively, it is also conceivable that activated Kit-induced PI3K stimulation may also interfere with DNR-induced apoptosis by regulating intracellular CER concentration.
Such hypotheses may have important clinical implication. Indeed, Kit is frequently expressed in acute myeloid leukemia (AML) and, in fact, was correlated with resistance to chemotherapy (Ashman et al., 1988; Cole et al., 1996; Ikeda et al., 1991; ReussBorst et al., 1994) . Moreover, systemic mastocytosis, in which Kit was frequently found to be activated by point mutations in its intracellular domain, is also refractory to antileukemic agents (Longley et al., 1996; Nagata et al., 1997) . Therefore, both molecular and clinical evidences support a role for Kit signaling in the resistance of Kit expressing malignant cells.
This study was aimed to evaluate the in¯uence of Kit activation by SCF or by modi®cation in the intracellular domain on DNR-activated SM cycle and apoptosis, and to investigate the mechanism by which Kit signaling may interfere with SM-CER apoptotic pathway.
Results

Kit activation inhibits DNR-induced cytotoxicity
Ba/F3-wt cells, Ba/F3-KitD27 cells, Ba/F3-Kit cells, and Ba/F3-Kit cells stimulated with SCF (250 ng/ml) for 15 min, were cultured either in RPMI medium with 10% FCS in the presence of IL-3 or in RPMI medium with 1% FCS in the absence of IL-3, and treated with 1 mM DNR for 24 h. Cell viability was assessed by trypan blue exclusion assay (Figure 1 ). In Ba/F3-wt cells cultured in medium with 10% FCS in the presence of IL-3, DNR induced 87+7% cytotoxicity, compared to untreated cells. DNR induced similar cytotoxicity in Ba/F3-Kit cells. However, Ba/F3-Kit cells pretreated with SCF for 15 min were signi®cantly more resistant than unstimulated cells. DNR-induced cytotoxicity was also reduced in Ba/F3-KitD27 cells compared to Ba/ F3-wt or Ba/F3-Kit cells. Sensitivity to DNR was similar in Ba/F3-KitD27 cells and SCF-stimulated Ba/ F3-Kit cells, and was 2 ± 3-fold lower than that of Ba/ F3-wt cells or unstimulated Ba/F3-Kit cells. Altogether these results showed that, in the presence of IL-3, Kit activation either by SCF or by modi®cation of its intracellular domain aords signi®cant protection against DNR. The magnitude of SCF chemo-protective eect was not modi®ed by IL-3 or FCS concentrations (Figure 1 ).
Kit activation inhibits DNR-induced apoptosis
Ba/F3-wt, Ba/F3-KitD27, Ba/F3-Kit +/7 SCF cells were cultured either in RPMI medium with 10% FCS in the presence of IL-3 or in RPMI medium with 1% FCS in the absence of IL-3, and treated with 1 mM DNR for 10 h. DNR induced apoptosis in Ba/F3-wt and Ba/F3-Kit as measured by DAPI staining (Figure  2a Kit signaling interferes with DNR-induced apoptosis in Ba/F3 cells. Since neither IL-3 nor FCS concentrations in¯uenced DNR-induced cytotoxicity and apoptosis, subsequent experiments were performed in 1% FCS and without IL-3 in order to minimize possible interferences between Kit signaling and non-speci®c stimuli.
Influence of Kit activation on DNR-induced N-SMase stimulation
Ba/F3-wt, Ba/F3-KitD27, Ba/F3-Kit +/7 SCF cells were cultured in IL-3-deprived medium with 1% FCS, then treated with 1 mM DNR. N-SMase activity was monitored over 1 h as previously described . DNR stimulated N-SMase activity with a maximum of 129 ± 177% increase within 4 ± 15 min in Ba/F3-wt and Ba/F3-Kit cells but not in Ba/F3-KitD27 and Ba/F3-Kit+SCF cells (Figure 3 ). These results showed that DNR triggered N-SMase activity in Ba/F3 cells with a similar magnitude and kinetics than previously documented in other leukemic cellular models (Allouche et al., 1997 (Allouche et al., , 2000 BettaõÈ eb et al., 1999; CoÃ me et al., 1999; JareÂ zou et al., 1996; Mansat et al., 1997a,b) , and that Kit activation blocked DNRinduced SMase stimulation.
Influence of Kit activation on DNR-induced CER production
Ba/F3-wt, Ba/F3-KitD27, Ba/F3-Kit +/7 SCF cells were cultured in IL-3-deprived medium with 1% FCS, then treated with 1 mM DNR. CER production was monitored according to both metabolic labeling and DAG kinase assay. Using the former, we found that DNR induced a signi®cant boost (20 ± 30%) in intracellular CER accumulation in Ba/F3-wt and Ba/F3-Kit cells but not in Ba/F3-KitD27 and Ba/F3-Kit+SCF cells. In the sensitive cells, CER generation correlated with DNRinduced N-SMase stimulation (Figure 4) . In order to con®rm and provide quantitative evaluation of intracellular CER concentration, we used DAG kinase assay. This assay revealed no striking dierences in basal intracellular CER concentrations whether or not Kit Figure 2 Kit activation inhibits DNR-induced apoptosis. Ba/F3-wt, Ba/F3-KitD27, Ba/F3-Kit cells treated or not with 250 ng/ml SCF for 15 min were incubated with 1 mM DNR in FCS/IL-3 deprivation conditions. Cytochemical analysis (a) or speci®c DNA fragmentation (b) was analysed 10 h later as described in Materials and methods. Results are mean+s.d. of at least three independent experiments. Statistical analyses were performed using the student's t-test and the asterisk represents signi®cant dierences (P50.05) compared with Ba/F3-wt and Ba/F3-Kit cells (Table 1) .
Effect of cell-permeant exogenous CER on Ba/F3 cell viability
Ba/F3-wt, Ba/F3-KitD27, Ba/F3-Kit +/7 SCF (250 ng/ml) cells were cultured in IL-3-deprived medium with 1% FCS, then treated with 10, 25, or 50 mM exogenous C6-CER for 10 h. Cell viability was measured by MTT assay. As shown in Figure 5 , Kit activation conferred no signi®cant protection towards C6-CER when used at 50 mM.
Altogether these results suggest that Kit activation results in decreased DNR cytotoxicity by limiting DNR-induced N-SMase stimulation and CER accumulation
Role of PI3K in the inhibition of DNR-induced N-SMase stimulation by Kit signaling
Based on previously documented role of PI3K in Kitmediated cell death protection (Timokhina et al., 1998) , we investigated the in¯uence of LY294002, a PI3K inhibitor, on DNR cytotoxicity in SCF-stimulated Ba/F3-Kit cells and in Ba/F3-KitD27 cells. Preliminary experiments were performed in order to de®ne optimal conditions for inhibiting PI3K/Akt pathway in these cells. We found that treatment with LY294002 at 20 mM for 1 h inhibited Akt phosphorylation in Kit-activated Ba/F3 cells as revealed by immunoblot analysis with an anti-phospho-Akt antibody, whereas Akt expression was found unchanged (Figure 6, insert A) . Under these conditions, we found that PI3K inhibition had no in¯uence on DNA fragmentation induced by DNR (1 mM) ( Figure 6 , insert B) and did not increase DNR-induced cytotoxicity in Kit-activated Ba/F3 cells ( Figure 6 ). Moreover, PI3K inhibition did not restore DNR-induced N-SMase stimulation in these cells (data not shown). These results suggest that PI3K was not involved in Kit-mediated protection.
Role of PKC in the inhibition of DNR-induced N-SMase stimulation and CER generation by Kit signaling
Since PKC has been described to play an important role in the regulation of DNR-induced SMase stimulation and CER production (Mansat et al., 1997b) , we have hypothesized that Kit signaling may interfere with DNRtriggered SM cycle through a PKC-dependent mechanism. For this reason, we have investigated the in¯uence of two PKC inhibitors, calphostin C alone and chelerythrin alone, on the capacity of DNR to stimulate N-SMase in Ba/F3-KitD27 and in Ba/F3-Kit cells treated with SCF. Chelerythrin inhibits all PKC isoforms whereas calphostin C, which interferes with the regulatory sites of classical and novel PKC isoforms, does not inhibit atypical PKC isoforms. Neither chelerythrin (10 mM for 1 h) nor calphostin C (100 nM for 1 h) in¯uenced N-SMase activity, compared to untreated cells (data not shown).
However, both chelerythrin and calphostin C restored the capacity of DNR to induce N-SMase stimulation with a maximum increase of 120 ± 130% within 4 ± 15 min ( Role of SCF-mediated Kit activation on PLCg activation, DAG production, PKC stimulation, and N-SMase inhibition in Ba/F3-Kit cells Ba/F3-Kit cells were treated with SCF (250 ng/ml) in RPMI medium containing 1% FCS in the absence of IL-3, then PLCg tyrosine phosphorylation status, intracellular DAG level, and PKC activity were monitored at various times. As shown in Figure 8a , SCF induced a rapid increase in PLCg tyrosine phosphorylation which culminated at 1.5 min. Moreover, SCF induced DAG accumulation with a plateau at 5 ± 10 min which was inhibited by 2 mM U-73122, a potent PLCg inhibitor (Bleasdale et al., 1989) ( Figure   Figure 4 In¯uence of Kit activation on DNR-induced CER generation. Ba/F3-wt, Ba/F3-KitD27, Ba/F3-Kit cells treated or not with 250 ng/ml SCF for 15 min were incubated with 1 mM DNR in FCS/IL-3 deprivation conditions. Cells were pre-labeled with 8b). PKC activity was tested by measuring MBP phosphorylation of cell lysates immunoprecipitated with MC5 monoclonal antibody which reacts with a conserved region of mouse PKC (Young et al., 1988) . As shown in Figure 8c , SCF induced within 7 ± 15 min PKC activity stimulation that was inhibited by U-73122. These results suggested that PLCg-mediated DAG production was responsible for the stimulation of classical or novel PKC isoform(s). Among these, we have investigated the possible contribution of PKCa, PKCb, and PKCd. After immunoprecipitation with speci®c antibodies, we found that SCF induced U-73122-inhibitable PKCb stimulation ( Figure 8d ) whereas it had no eect on PKCa and PKCd activities (data not shown). Finally, pretreatment with 2 mM U-73122, but not with U-73343, an inactive analog of U-73122, restored DNR-induced N-SMase stimulation ( Figure 9a ) and CER generation ( Figure  9b ). Altogether, these results suggest that DAG issued from PLCg-mediated PI hydrolysis was responsible for PKCb stimulation which, in turn, interfered with DNR-induced N-SMase stimulation and CER production.
Role of constitutive Kit activation on PKC stimulation and N-SMase inhibition in Ba/F3-KitD27 cells
Based on the above results, we reasoned that constitutive activation of Kit may also result in PLCg-dependent PKC activation and subsequent N-SMase inhibition. In fact, in Ba/F3-KitD27 cells, anti PKC (MC5) immunoprecipitates exhibited higher enzymatic activity, compared to Ba/F3-wt or unstimulated Ba/F3-Kit cells, but similar to that of Ba/F3-Kit cells stimulated by SCF (Figure 10a ). This result was con®rmed by measurement of global PKC activity: 133+19 and 46+17 pmol ATP/ minute/mg of protein for Ba/F3-KitD27 cells and Ba/ F3-wt, respectively. Furthermore, Ba/F3-KitD27 cells displayed a higher PKCb activity, compared to Ba/F3-Kit cells (Figure 10b ) whereas PKCa and PKCd activities of these two cell lines were comparable (data not shown). Treatment of Ba/F3-KitD27 cells with 2 mM U-73122 for 1 h resulted in decreased PKCb activity ( Figure 10b ) whereas it had no eect on other PKC isoforms tested (data not shown). Finally, U-73122, but not with U-73343, restored DNR-induced N-SMase stimulation (Figure 10c ) as well as CER generation (Figure 10d ). These results paralleled those obtained in SCF-stimulated cells and suggested that constitutive Kit activation results also in PLCg-mediated PKCb overactivity responsible for N-SMase inhibition. 
Effect of PLCg inhibition on DNR-induced apoptosis in SCF-stimulated cells
Based on the role of PLCg in inhibition of DNRtriggered CER production, we hypothesized that PLCg inhibition could result in increased DNR-induced DNA fragmentation and cytotoxicity in Kit-activated cells. Therefore, SCF-stimulated Ba/F3-Kit cells were pretreated with 2 mM U-73122 for 1 h, then co-treated with 1 mM DNR and U-73122 for 10 h. U-73122 alone had a marginal eect on DNA fragmentation (less than 10%) (data not shown). However, as shown in Figure  11 , U-73122 enhanced DNR-induced DNA fragmentation in SCF-stimulated Ba/F3-Kit cells whereas this compound did not in¯uence the chemosensitivity The chemosensitizing eect of U-73122 was also investigated in HMC-1 cells, a human mastocytic leukemia cell line with an active mutated form of Kit (Furitsu et al., 1993) . Interestingly, these cells were found to be extremely sensitive to U-73122 alone. Indeed, sub-toxic concentrations (i.e., dose needed to achieve less than 10% cytotoxicity) were found to be 40-fold lower, compared to Ba/F3 cells (data not shown). For this reason, HMC-1 were pretreated with U-73122 at a dose as low as 50 nM, then co-treated with 1 mM DNR and U-73122 for 15 h, and cell viability was assessed by trypan blue assay. Whereas DNR alone had virtually no eect, the combination of DNR and U-73122 induced 30% cytotoxicity ( Figure  12 ).
Discussion
Previous studies have shown that SCF suppressed apoptosis induced by g-radiation in vitro and protected mice and dogs from radiation-induced hematopoietic and intestinal cell death in vivo (Leigh et al., 1995; Neta et al., 1993; Schuening et al., 1993; Yee et al., 1994; Zsebo et al., 1992) . The in¯uence of Kit activation on the cellular response to chemotherapeutic compounds has been much less investigated. However, in a previous study, it has been described that SCF may reduce drug-induced apoptosis in fresh CD34+ AML cells (Hassan and Zander, 1996) . Our study con®rms these ®ndings and shows that not only SCF activated receptor but also structural changes in Kit intracellular domain, may signi®cantly reduce DNR-induced apoptosis and cytotoxicity. Kit activation did not in¯uence DNR accumulation and eux, as assessed by¯ow cytometry (data not shown). Therefore, we hypothesized that Kit signaling interfered with DNR-triggered apoptotic signals.
Dierent mechanisms of Kit-mediated suppression of apoptosis have been proposed, depending on the cellular model and stress conditions. For example, it has been suggested that the protective eect of SCF on growth factor deprivation-induced apoptosis of NK cells could be related to SCF-induced Bcl-2 overexpression (Carson et al., 1994) whereas Bcl-2 plays no role in Kit-mediated suppression of mast cell apoptosis induced by serum withdrawal (Yee et al., 1994) . In mast cells, previous studies have emphasized the role of PI3K/Akt/Bad pathway in Kit-mediated inhibition of apoptosis (Blume-Jensen et al., 1994 . Further studies have suggested that Kit-mediated radioprotection is essentially due to inhibition of g-irradiationinduced JNK activation through a PI3K-and Srcdependent mechanism (Timokhina et al., 1998) . However, based on our previous studies which demonstrated the role of the SM cycle in DNRinduced apoptosis (Allouche et al., 1997 (Allouche et al., , 2000 BettaõÈ eb et al., 1999; CoÃ me et al., 1999; JareÂ zou et al., 1996; Mansat et al., 1997a,b) , we hypothesized that Kit signaling interferes with CER production or/and CERinduced apoptosis. Preliminary experiments showed that Ba/F3 cells displayed dierent sensitivities to exogenous CER. For example, Ba/F3-Kit cells were found to be more sensitive to CER than Ba/F3-wt or Ba/F3-KitD27. The reason of Ba/F3-Kit higher sensitivity is unclear unless these cells displayed some regulatory mechanisms known to interfere with CER toxicity such as anti-oxydant defenses or Bcl-2 overexpression (Allouche et al., 1997; Quillet-Mary et al., . However, we found that Kit activation did not result in signi®cant protection against CER cytotoxicity. For example, Ba/F3-kit cells displayed similar sensitivities whether or not SCF was maintained in the culture medium and Ba/F3-KitD27 were found to equally sensitive to CER than Ba/F3-wt. Therefore, we postulated that Kit signaling interfered upstream CER generation. In fact, our study clearly shows that Kit activation seriously limited DNR-induced NSMase stimulation and subsequent CER production.
Thus, it is conceivable that kit activation may also interfere with g-radiation-induced apoptosis since it has been already documented that g-irradiation activates the SM cycle in leukemic cells (Bruno et al., 1998) . We are currently investigating this hypothesis in Ba/F3 cellular models. Based on the inhibitory role of PKC in N-SMase regulation (Chmura et al., 1996; Mansat et al., 1997b) , we hypothesized that Kit activation resulted in PKC stimulation and subsequent inhibition of DNR-induced (Blume-Jensen et al., 1998; Haslauer et al., 1999) . However, the mechanism by which Kit signaling in¯uences PKC activity remains controversial. This study described for the ®rst time a signaling cascade which consists in PLCg activation, DAG production and PKCb stimulation. Previous studies have documented that, in mast cells, SCF stimulates phosphatidylcholine (PC)-phospholipase D (PLD) activity with subsequent production of phosphatidic acid (PA), and that PA could be metabolized to DAG through phosphatidate phosphohydrolase (Koike et al., 1993; Kosawa et al., 1997) . The fact that U-73122 inhibited DAG production and PKC stimulation minimized the putative role of PLD in PKC regulation at least in Ba/F3 cells. The cellular model may also in¯uence the respective role of PKC isozymes involved in Kit signaling. Indeed, it has been recently described that PKCa is the major intermediate eector of Kit signaling in normal human progenitors (Haslauer et al., 1999) whereas we found no stimulation of PKCa in Kit-activated Ba/F3 cells.
The fact that PKC stimulation occurred before maximal N-SMase activation was consistent with a possible link between PKC stimulation and N-SMase inhibition. Moreover, since calphostin C restored DNR-induced N-SMase stimulation, one could speculate that classical or novel PKC isozyme(s) may be involved in N-SMase regulation. Based on the observation that PKCb, but not PKCa or PKCd, was stimulated, PKCb represents a plausible candidate for regulating N-SMase although we cannot rule out the contribution of other classical or novel PKC isoform(s). The fact that PKCb was previously involved in drug resistance, supports this hypothesis (Fan et al., 1992) .
The role of PI3K in Kit-induced cellular protection was also investigated. In fact, we found that Kit activation resulted in Akt phosphorylation in both SCF-stimulated Ba/F3-Kit and in Ba/F3-KitD27 cells, suggesting that PI3K/Akt pathway is activated by Kit in these cellular models. However, the fact that LY294002, a PI3K inhibitor, was able to inhibit Akt phosphorylation but unable to restore DNR-induced N-SMase stimulation in Kit-activated cells, suggests that PI3K was likely not involved in Kit-mediated suppression of DNR-apoptosis.
Therefore, we propose a model in which Kit activation results in PLCg stimulation responsible for PI hydrolysis and subsequent DAG production and PKC stimulation which, in turn, inhibits DNRinduced N-SMase activation and CER production. Our study designated PLCg activity as a critical parameter in regulating DNR-activated SM cycle and apoptosis. The fact that PLCg may regulate drug-activated SM cycle may have other clinical implications beyond the scope of Kit-associated malignant diseases. Indeed, PLCg can be activated by a large variety of lipids messengers, receptor and non-receptor tyrosine kinases, and oncogenic products distinct from Kit such as p21ras (Lee and Rhee, 1995; Rhee et al., 1991; Rizzo et al., 1991) . Therefore, PLCmediated external or internal signals could severely limit the cytotoxicity of antitumor agents which have been found to activate the SM cycle. It has been recently suggested that PLC could play a role in multidrug resistance (MDR) by regulating the function of P-glycoprotein in MDR cells (Yang et al., 1997) . Figure 11 Eect of PLCg inhibition on DNR sensitivity of Ba/ F3 cells. Ba/F3-wt and Ba/F3-Kit cells were exposed to 1 mM DNR in the presence (&), or in the absence of U-73122 (&) in FCS/IL-3 deprivation and total DNA fragmentation was analysed 10 h later as described in Materials and methods. Results are mean+s.d. of at least three independent experiments. Statistical analyses were performed using the student's t-test and the asterisk represents signi®cant dierences (P50.05) compared with untreated cells Figure 12 Eect of PLCg inhibition on DNR sensitivity of human malignant mast cells HMC-1. HMC-1 cells were exposed to DNR in the presence or in the absence of U-73122 (50 nM, 1 h), and cell viability was measured as described in Materials and methods. Results are mean+s.d. of at least three independent experiments. Statistical analyses were performed using the student's t-test and the asterisk represents signi®cant dierences (P50.05) compared with untreated cells c-Kit inhibits DNR-induced apoptosis I Plo et al
Our study suggests that PLC may also in¯uence drug cytotoxicity in non-MDR cells.
To conclude, our results ®t with a model in which Kit signaling interferes with drug-activated SM cycle and apoptosis through a PLCg-and PKC-dependent mechanism. The fact that PI hydrolysis inhibition results in chemosensitization of Kit activated cells, including human mastocytic tumor cells, oers a promising approach for future pharmacological manipulations in order to improve the ecacy of chemotherapy in systemic mastocytosis and in AML.
Materials and methods
Materials
Murine SCF was obtained either from puri®cation of CHO-KL supernatant cells or from R&D (Abigdon, UK). DNR was from Roger Bellon (Neuilly/Seine, France). LY294002, U-73122, U-73343 were purchased from CalBiochem (San Diego, CA, USA). Calphostin C, chelerythrin, TPA (phorbol 12-myristate 13-acetate), anti-PKCb, myelin basic protein (MBP) were from Sigma (St Quentin-Fallavier, France). Cell permeant CER (C6) was provided by Alexis (Coger, France). Anti-PLCg antibody (1249) and antibodies directed against either all PKC isozymes (MC5) or PKCd (C-17) were from Santa-Cruz, TEBU (Le Perray en Yvelines, France). Antiphosphotyrosine (PY-20) was obtained from Transduction Laboratories (Pantin, France). Anti-PKCa antibody was purchased from Euromedex (Souelweyersheim, France). Anti-phospho-Akt and Anti-Akt were from New England Biolabs (Beverly, USA). [g- 
Cell culture
Ba/F3-wt, a murine IL-3-dependent pro-B lymphoid cell line, was cultured in RPMI 1640 medium supplemented with 10% FCS, 2 mM glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin and 10% of conditioned media from WEHI cells containing interleukin 3 (IL-3). Ba/F3-Kit cells are Ba/ F3 cells transfected with LXSN-Kit and cultured in the same medium. Ba/F3-KitD27 cells are Ba/F3 cells rendered IL-3 independent by transfection with a mutant form of Kit which is constitutively active as a result of a deletion in its juxtamembrane domain (De Sepulveda et al., 1999; Casteran et al. unpublished data) . Ba/F3-KitD27 was cultured in RPMI 1640 supplemented with 10% FCS. CHO-KL were CHO cells transfected with the Kit ligand (gift from Immunex) and cultured in DMEM supplemented with 10% FCS. HMC-1 is a human mast cell leukemia cell line in which Kit was found to be constitutively tyrosine phosphorylated in relation with Val-560-4Gly (G560) and mutations in the juxtamembrane domain and the phosphotransferase domain, respectively (Furitsu et al., 1993) . HMC-1 were cultured in RPMI 1640 medium supplemented with 10% FCS.
Drug cytotoxicity studies
Cells were treated with cytotoxic agents (DNR, C6-CER) in 10% FCS in the presence of IL-3 or in RPMI 1640 medium with 1% FCS in the absence of IL-3. Cell viability was measured either by trypan blue exclusion or by MTT assay.
Determination of DNA fragmentation
DNA fragmentation was quanti®ed as previously described (Quillet-Mary et al., 1996) . Exponentially growing cells (5610 5 /ml) were labeled for 24 h with 0.5 mCi/ 10 6 cells of [methyl-3 H]thymidine and washed three times with non radioactive fresh medium containing 10% FCS in the presence of IL-3 or in RPMI 1640 medium with 1% FCS in the absence of IL-3. Cells were then pretreated or not with U-73122 (1 h), and incubated for 10 h with DNR. Cells were harvested by centrifugation and the pellets were suspended in lysis buer containing 15 mM Tris, 20 mM EDTA and 0.5% Triton X-100, pH 8. After 30 min incubation on ice, samples were centrifuged at 20 000 g for 30 min. Pellets were resuspended in lysis buer. The radioactivity of the supernatant and pellet was evaluated by liquid scintillation counting. The percentage of fragmented DNA was calculated according to the following formula:
7 DNA fragmentation cXpXmX in supernatantacXpXmX in supernatant cXpXmX in pellet Â 100Y 7 specific fragmentation 7 DNA fragmentationÀ 7 spontaneous fragmentationa100 À 7 spontaneous fragmentation Â 100X
Cytochemical staining
Changes in nuclear chromatin were evaluated by¯uorescence microscopy by DAPI staining (Mansat et al., 1997b) . Cells (5610 5 ) were treated or not with DNR (1 mM), then washed and ®xed with paraformaldehyde (4%). After DAPI staining, cells were submitted to¯uorescence microscopy evaluation and counted. Results were expressed as percentage of cells with apoptotic ®gures.
Analysis of cellular phospholipids
Quantitation of CER and DAG was performed by labeling cells to isotopic equilibrium with [9,10(n)-3 H]palmitic acid (0.5 mCi/ml). After 48 h incubation, cells were washed and resuspended in serum-free medium for kinetic experiments, pretreated or not with inhibitors for 1 h, then treated or not with SCF (15 min, 250 ng/ml) and ®nally treated with DNR for the indicated times. Cellular lipids were extracted from aliquots (5610 6 cells) by the method of Bligh and Dyer (1959) and separated by thin layer chromatography (TLC) using chloroform/methanol/acetic acid/formic acid/water (65 : 30 : 10 : 4 : 2, by vol) followed by a second step using chloroform/methanol/acetic acid (95 : 5 : 5 by vol) as developing solvent system. Radioactive spots were scraped o and the amount of radioactivity was determined by liquidscintillation counting.
CER quantitation
CER quantitation was performed using Escherichia coli diacylglycerol kinase and [ 32 P]g-ATP (3300 Ci/mmol). Cells (5610 6 ) were washed in PBS and lipids were extracted by the method of Bligh and Dyer (1959). Lipids were incubated at room temperature for 30 min in the presence of b-octylglucoside/dioleoyl-phosphatidyl glycerol vesicles, 2 mM dithiothreitol, 5 mg of proteins from DAG kinase membranes, and 2 mM ATP (mixed with 0.01 mCi [g-32 P]ATP) in a ®nal volume of 100 ml. At the end of incubation period 20 ml of 1% (v/v) perchloric acid and 450 ml of chloroform : methanol (1 : 2, v/v) was added. Tubes were left at room temperature for 10 min and centrifuged at 2000 g for 1 min. Following centrifugation, 150 ml of chloroform and 150 ml of 1% perchloric acid were added and the upper phase was removed. Lower phase was washed twice with 1% perchloric acid and after evaporation ceramide-phosphate (CER-P) was resolved on TLC plates (chloroform/methanol/acetic acid) (65 : 15 : 5, v/v/v) . Radioactive spots were scraped o and the amount of radioactivity was determined by liquid-scintillation counting. Results were expressed in pmol of CER/ mg of protein using a range of CER standard (0 ± 1000 pmol) submitted to the same experiment.
Neutral SMase assay
SMase activity was assayed as previously described using [choline-methyl-14 C]sphingomyelin (120 000 d.p.m./assay) as substrate (JareÂ zou et al., 1996) .
PLCg phosphorylation analysis
After treatment of cells (5610 6 /ml) with SCF (250 ng/ml) for various times, cells extracts were prepared by lysing cells in buer containing 50 mM HEPES pH 7.0, 1 mM EDTA, 150 mM NaCl, 10% glycerol, 1% Triton X-100, 1.5 mM MgCl 2 , 10 mM Na 4 P 2 O 7 , 100 mM NaF, 1 mM NaVO 3 , 10 mg/ml leupeptin, 10 mg/ml aprotinin, 1 mM PMSF, and 10 mM DTT. Cells extracts (300 mg) were immunoprecipitated with 3 mg anti-phosphotyrosine (PY-20) overnight at 48C. Immune complexes were collected by incubation with protein G-sepharose beads for 60 min at 48C. The beads were extensively washed with buer containing 50 mM HEPES pH 7.0, 10% glycerol, 0.1% Triton X-100, 1 mM NaVO 3 , 150 mM NaCl). Denaturing loading buer was added to immune complexes, boiled for 5 min and the samples were loaded in a SDS ± PAGE (7.5%), transferred onto nitrocellulose membrane and probed with anti-PLCg antibody. Proteins were detected by chemoluminescent detection system.
Akt phosphorylation analysis
After pretreatment of cells with LY294002 or not, cells were treated with SCF (250 ng/ml) for 15 min and lysed in a denaturing loading buer and 30 mg of protein were loaded in a SDS ± PAGE (10%), transferred onto nitrocellulose and probed with anti-phospho-Akt or anti-Akt antibodies. Proteins were detected by chemoluminescent detection system.
Assay for PKC activity
Cells (5610 6 /ml) were incubated for 15 min with SCF (250 ng/ml) and lysed in 0.3 ml of ice cold extraction buer (25 mM Tris-HCl pH 7.4, 10 mM bmercaptoethanol, 0.5 mM EGTA, 0.5 mM PMSF, 1 mg/ml leupeptin, and 1 mg/ml aprotinin). PKC activity was assayed by measuring the incorporation of 32 P from ATP into Neurogranin 28 to 43 peptide (Chen et al., 1993) using the signaTECT PKC Assay System as described by the supplier. Results were expressed as pmol 32 P incorporated into neurogranin peptide per minute per milligram protein.
PKC isoforms activity
After treatment with SCF, cells (5610 6 /ml) were lysed in buer containing 20 mM HEPES pH 7.4, 0.5 M EDTA, 125 mM NaCl, 0.1% NP40, 1 mM NaVO 3 , 2 mg/ml leupeptin, 2 mg/ml aprotinin, 1 mM PMSF, 0.5 mg/ml benzamidine, and 1 mM DTT. Cells extracts (150 ± 200 mg) were immunoprecipitated with 3 mg anti-classical PKC or anti-PKCa or antiPKCd or anti-PKCb antibodies overnight at 48C. Immune complexes were collected by incubation with protein Gsepharose beads for 60 min at 48C. The beads were extensively washed with lysis buer and twice with kinase buer (20 mM HEPES pH 7.4, 1 mM DTT, 25 mM NaCl). Kinase assays were performed for 15 min at 328C using MBP as a substrate in 20 mM HEPES pH 7.4, 10 mM MgCl 2 , 1 mM DTT and 10 mCi [g-32 P]ATP. Reactions were stopped by addition of 15 ml 26SDS buer, boiled for 5 min and the samples were loaded in a SDS ± PAGE (10%). Phosphorylated MBP levels were analysed by autoradiography.
